INTRODUCTION
In neutrophils, activation of protein kinase C (PKC) by phorbol 12-myristate 13-acetate (PMA) or dioctanoylglycerol results in the activation of the NADPH oxidase, inducing a so-called respiratory burst (reviewed in [1] ). Probably, phosphorylation of p47-phox, one of the components of this enzyme system, by activated PKC is a key event in this response [2, 3] . However, the role of PKC in the activation of the burst by stimulation of various cell-surface receptors has been questioned [4] [5] [6] [7] , mostly on the basis of experiments with the potent but non-specific protein kinase inhibitor staurosporine. This compound has been reported to enhance the oxidative burst after stimulation of neutrophils with the receptor agonist N-formylmethionyl-leucylphenylalanine (fMLP) [8] , or to inhibit this response, especially when the second phase is considered [7] . Compound Ro 31-8425, a staurosporine analogue with improved specificity for PKC, does inhibit the respiratory burst after activation of various cellsurface receptors, but at 4-20-fold higher concentrations than required for inhibition of a dioctanoylglycerol-induced response [9] .
Recently, the activation of phospholipase D (PLD) resulting in the production of phosphatidic acid has been suggested to play in a lower efficacy of inhibition. Activation of PLD by fMLP was enhanced in the presence of staurosporine, but not in the presence of cgp41251. Enhancement of PLD activation was also observed in the presence of H-89, an inhibitor of cyclic-AMP-dependent protein kinase (PKA). Both staurosporine and H-89 reversed the dibutyryl-cyclic-AMP-induced inhibition of PLD activation, whereas cgp41251 was without effect. These results indicate that the potentiating effect of staurosporine on PLD activation induced by fMLP does not reflect a feedback inhibition by PKC activation, but instead a feedback inhibition by PKA activation. Taken together, our results indicate that in human neutrophils: (i) PKC activity is not essential for fMLP-induced activation of PLD; (ii) PKC activity does play an essential role in the activation of the respiratory burst by fMLP, other than mediating or modulating PLD activation; (iii) there exists a negative-feedback mechanism on fMLP-induced PLD activation by concomitant activation of PKA.
an important role in the activation of the neutrophil respiratory burst [10] [11] [12] . The mechanism by which receptor-mediated activation of PLD is regulated is not yet fully understood. A regulatory role for (a) G-protein(s) in PLD activation independent ofinducing Ca2l changes is suggested by the observation that fMLP-induced activation of PLD in electropermeabilized neutrophils (in which the free Ca2+ concentration is buffered at 1 uM [13] ) is dependent on the presence of GTP (G. C. R. Kessels and A. J. Verhoeven, unpublished work). Furthermore, nonhydrolysable GTP analogues are able to stimulate PLD activity in electropermeabilized neutrophils [14] or in electropermeabilized HL-60 cells [15] . The latter study also showed that ATP greatly potentiated this response, suggesting the involvement of a protein kinase. An obvious candidate for this protein kinase would be PKC, because the phorbol ester PMA causes the activation of PLD in several cell types [16, 17] . However, studies in which more or less specific inhibitors of PKC were used have revealed rather confusing results [16, 18, 19] . Studies with various tyrosine kinase inhibitors [20] have suggested that the fMLP-induced activation of PLD depends on the activity of tyrosine kinases in the neutrophil. In the course of our studies on the kinase involvement in PLD activation, we observed that staurosporine (commonly used to inhibit PKC activity) caused a considerable enhancement of the fMLP-induced PLD activity, although staurosporine has been shown to inhibit total neutrophil tyrosine kinase activity almost as potently as PKC activity [21] .
To determine in more detail the role of PKC in receptormediated respiratory-burst activation and in concomitant PLD activation, we have used a structural analogue of staurosporine (cgp41251) that reflects higher selectivity towards PKC [22] . The results presented here suggest that PKC is not involved in the activation of PLD as induced by the receptor agonist fMLP, because of the failure of compound cgp41251 to influence this response. The potentiating effect of staurosporine does not reflect a feedback inhibition by PKC activation, but instead a feedback inhibition by activation of cyclic AMP-dependent protein kinase (PKA). Since compound cgp41251 does interfere with the fMLP-induced respiratory burst, it can be concluded that PKC plays an essential role in this response other than mediating or modulating PLD activation. 
MATERIALS AND METHODS

Materials
Cell isolation
Blood was obtained from healthy volunteers. Granulocytes were purified from the buffy coat of 500 ml of blood anticoagulated with 0.40% trisodium citrate (pH 7.4), as described [23] . After isolation, the cells were resuspended in incubation medium containing 132 mM NaCl, 6.0 mM KCI, 1.0 mM CaCl2, 1.0 mM MgSO4, 1.2 mM potassium phosphate, 20 mM Hepes, 5.5 mM glucose and 0.5 % (w/v) human serum albumin (pH 7.4), and kept at room temperature until use.
Measurement of PLD activity PLD activity was measured in neutrophils that had been prelabelled in the phosphatidylcholine pool with [3H]-lysophosphatidylcholine as described previously [14] . In short, 20 x 106 neutrophils/ml of incubation medium without human serum albumin and without CaCl2 were incubated for 60 min in a shaking water bath at 37 'C in the presence of [3H]-lysophosphatidylcholine (2-4 4Ci/20 x 106 cells). Subsequently, the cells were washed and resuspended in incubation medium (107/ml) containing human serum albumin (0.5%) and CaCl2 (1 mM). After incubation at 37 'C for 5 Measurement of superoxide production Superoxide production was measured by the superoxide dismutase-sensitive reduction of cytochrome c in a continuous spectrophotometric assay with a Perkin-Elmer spectrophotometer (model Lambda 2 UV/VIS). The contents of six cuvettes measured in parallel was stirred continuously and thermostatically maintained at 37 'C. Neutrophils were resuspended in incubation medium containing 60,uM cytochrome c at a concentration of 106 cells/ml. After 5 min of preincubation in the presence of cytochalasin B (5 jig/ml), the cells were pretreated with the inhibitor or Me2SO for 5 min, and subsequently stimulated with fMLP. When dBcAMP was present during the incubation, the cells were first incubated with dBcAMP before addition of cytochalasin B.
RESULTS
Effect of staurosporine analogues on respiratory-burst activation in human neutrophils We first investigated the effect of staurosporine and cgp41251 on PMA-induced superoxide production, because this response is generally believed to be mediated by PKC. Both staurosporine and cgp41251 dose-dependently inhibited the production of superoxide induced by PMA (Figures la and lb) . The inactive structural analogue cgp42700 had no effect at all (results not shown). The difference in efficacy between staurosporine and its analogue cgp41251 is in accordance with the reported difference in IC50 values for PKC inhibition [22] . Niggli and Keller [24] have shown that both staurosporine and cgp41251 inhibit the PMA-induced phosphorylation of the 47 kDa PKC substrate in intact neutrophils.
We also evaluated the effect of these inhibitors on the fMLPinduced respiratory burst. Staurosporine was more potent in inhibiting the PMA-induced respiratory burst than the fMLPinduced burst (Figure la) . Similar results were obtained with the more specific inhibitor cgp41251 ( Figure Ib) . For instance, in the presence of 100 nM staurosporine or 1 ,uM cgp41251, the PMAinduced burst was completely inhibited, whereas fMLP was able to initiate oxidase activation ( Figure 2 ). However, propagation of the fMLP-induced response was severely inhibited in the presence of either staurosporine or cgp41251 (Figure 2 occurring in the latter situation and cannot be considered as a clear indication for PKC-independent activation ofthe respiratory burst.
Effect of staurosporine analogues on fMLP-induced PLD activation
Since PLD activation is thought to play an important role in neutrophil activation [10] [11] [12] [13] [14] , we investigated the effects of cgp41251 and the parent compound staurosporine on fMLPinduced PLD activation. Compound cgp41251 had no effect on fMLP-induced PLD activity in concentrations up to 10,uM (Figure 4) , whereas respiratory-burst activation was greatly attenuated in the presence of this inhibitor (Figure lb) . Thus it seems that PKC activity is not involved in the activation of PLD by fMLP. The parent compound staurosporine caused a concentrationdependent potentiation of PLD activity after fMLP stimulation (Figure 4) . Previously, this result has been found by Reinhold et al. [19] . Considering the lack of effect of cgp41251 on this response, it seemed probable that the enhancement caused by staurosporine was due to an action of this compound other than PKC inhibition. It has been shown that fMLP stimulation of neutrophils also results in elevation of cyclic AMP levels [25] . Possibly a negative control exerted by PKA might be lost in the presence of staurosporine, since PKA is potently inhibited by staurosporine, but much less potently by cgp41251 [22] . Indeed, fMLP-induced activation of PLD was enhanced in the presence of 30,M H-89 (Figure 4) PKA [26] . [26] , was able to duplicate the staurosporine effect on PLD activation (Figure 4 ). The second notion is based on the lack of effect of cgp41251 to interfere with fMLP-induced PLD activation (Figure 3 ), despite its ability to interfere with respiratory-burst activation ( Figure  lb ). This lack ofeffect was not due to the higher cell concentration used in these PLD activity measurements (results not shown).
Since cgp41251 only interferes with the catalytic activity of PKC, another role for PKC, for instance as docking protein [27] , cannot be excluded.
The inability of staurosporine to prevent fMLP-induced PLD activation seems not in accordance with the purported involvement of a tyrosine kinase in the response [20, 28] . However, measurement of total tyrosine kinase activity in neutrophil membranes and cytosol [21] may not be indicative of the ability of staurosporine to inhibit this particular, as yet unidentified, tyrosine kinase.
Another problem in the use of staurosporine is the apparent decrease in potency to inhibit the PMA-induced response when the cytosolic free Ca2+ concentration is elevated. This problem is also encountered with the staurosporine analogue cgp41251 (Figure 3) . It may perhaps also be responsible for the increase in IC50 of other staurosporine derivatives when receptor-mediated stimulation of the respiratory burst is compared with dioctanoylglycerol-induced stimulation [9] . When this decrease in potency of cgp41251 is taken into consideration, our results indicate that PKC activity is required for fMLP-induced NADPH oxidase activation, both in the initial and in the second phase of this response. As noted above, this conclusion was not reached by Watson et al. [7] , but is in agreement with earlier observations by Kramer et al. [29] and Dewald et al. [30] . The latter group has postulated the requirement for two activation signals. One signal would be PKC activation and the other signal, according to present knowledge, would be PLD activation. This model can explain the inhibition of the fMLP-induced burst by cgp41251 (at the level of PKC activity) and by Ca2+ depletion [13, 18] , wortmannin [19] or ethanol [31] at the level of PLD activation. Our study clearly shows that PLD activation was not affected in the presence of cgp4125 1. However, respiratory-burst activation by fMLP was severely inhibited (Figures l b and 2 ). Thus it seems that PLD activity alone is not a strong enough signal to activate the respiratory burst, and that PKC activity is required together with PLD to stimulate the respiratory burst by fMLP.
In the present study we analysed fMLP-induced responses in the presence of cytochalasin B. In the absence of this agent, the fMLP receptor becomes rapidly bound to the cytoskeleton [32] . As a consequence, the fMLP-induced respiratory burst in the absence of cytochalasin B is very low or even absent [33] . It should be noted that the enhancement of fMLP-induced PLD activation caused by H-89 observed in the presence of cytochalasin B (Figure 4 ) did not significantly affect fMLPinduced superoxide generation (results not shown). Apparently, the great enhancement ofPLD activation after fMLP stimulation due to the presence of cytochalasin B [20] is already sufficient to allow maximal NADPH oxidase activity. However, when cytochalasin B was omitted from the incubation medium, the low oxidative response after fMLP stimulation was enhanced 3-fold in the presence of H-89 (results not shown), similar to the enhancement previously observed with staurosporine [8] .
The present study also suggests an important regulatory role of cyclic AMP generation during fMLP-induced activation of PLD. Our results obtained with H-89 (and with staurosporine) suggest that an increase in intracellular cyclic AMP as induced by fMLP activates PKA, which in its turn exerts a negative influence on PLD activation during fMLP stimulation. Recently, Tyagi et al. [34] and Agwu et al. [35] reported an inhibitory effect of dBcAMP pretreatment on fMLP-induced PLD activity. As yet, the mechanism by which PKA activation interferes with the activation of PLD has not been elucidated. Most probably, this regulation is at the level of the receptor or the receptor-coupled G-protein, because PMA-induced PLD activation was not influenced by cyclic AMP [31, 32] . In summary, this study shows that in human neutrophils data obtained with staurosporine cannot be properly interpreted, due to its ability to inhibit not only PKC activity, but also PKA activity. The use of cgp41251, a staurosporine analogue with improved selectivity, overcomes this problem, but even with this compound caution is warranted because the efficacy of inhibition of PKC is dependent on the intracellular Ca2+ concentration. With this caveat in mind, our results indicate an important role for PKC activation at all stages of the fMLP-induced respiratory burst, which is not at the level of fMLP-induced PLD activity.
